Exagen (XGN) Debt to Equity (2018 - 2026)

Exagen (XGN) has reported Debt to Equity for 9 consecutive years, with $1.58 the latest figure, recorded in Q1 2026.

• Debt to Equity for Q1 2026 came in at $1.58, down 51.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.58 (down 51.54% YoY), and the FY2025 annual result was $1.31, down 38.14% from the prior year.
• Debt to Equity was $1.58 for Q1 2026 at Exagen, up from $1.31 in the prior quarter.
• Over five years, Debt to Equity peaked at $3.27 in Q1 2025 and troughed at $0.36 in Q1 2022.
• Average Debt to Equity over 5 years is $1.14, with a median of $0.98 recorded in 2024.
• Year-over-year, Debt to Equity jumped 234.63% in 2025 and sank 51.54% in 2026.
• Over 5 years, Debt to Equity stood at $0.68 in 2022, then grew by 25.91% to $0.86 in 2023, then surged by 147.03% to $2.12 in 2024, then plunged by 38.14% to $1.31 in 2025, then increased by 20.71% to $1.58 in 2026.
• Per Business Quant data, the three most recent Debt to Equity figures were $1.58 in Q1 2026, $1.31 in Q4 2025, and $1.26 in Q3 2025.